Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
C

Camsing Healthcare Ltd
SGX:BAC

Watchlist Manager
Camsing Healthcare Ltd
SGX:BAC
Watchlist
Price: 1.07 SGD
Market Cap: S$3.9m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-78%
5Y
-
10Y
-
Liabilities
+
3Y
-28%
5Y
-
10Y
-
Equity
+
3Y
-19%
5Y
-
10Y
-

Balance Sheet Decomposition
Camsing Healthcare Ltd

Balance Sheet
Camsing Healthcare Ltd

Rotate your device to view
Balance Sheet
Currency: SGD
Jan-2002 Jan-2003 Jan-2004 Jan-2005 Jan-2006 Jan-2007 Jan-2008 Jan-2009 Jan-2010 Jan-2011 Jan-2012 Jan-2013 Jan-2014 Jan-2015 Jan-2016 Jan-2017 Jan-2018 Jan-2019 Jan-2020 Jan-2021 Jan-2022 Jan-2023 Jan-2024 Jan-2025
Assets
Cash & Cash Equivalents
4
7
0
0
20
3
3
5
7
4
6
5
5
5
0
6
5
1
1
1
0
0
0
0
Cash
0
0
0
0
0
0
3
5
7
4
6
5
0
0
0
0
0
0
0
0
0
0
0
0
Cash Equivalents
4
7
0
0
20
3
0
0
0
0
0
0
5
5
0
6
5
1
1
1
0
0
0
0
Short-Term Investments
6
4
18
12
0
0
2
3
4
5
5
3
1
0
4
0
0
0
0
0
0
0
0
0
Total Receivables
27
30
16
17
2
2
7
5
2
3
1
2
2
2
1
4
4
3
1
1
0
1
0
0
Accounts Receivables
27
30
16
17
2
2
6
4
1
2
1
1
2
2
1
4
4
3
1
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
Inventory
63
110
107
110
3
4
4
5
5
7
6
6
6
6
7
4
3
2
1
1
1
1
1
1
Other Current Assets
1
1
14
14
7
7
1
1
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Assets
100
152
153
152
32
15
16
18
18
20
18
17
14
13
12
13
13
6
3
2
2
2
1
1
PP&E Net
22
27
25
31
1
1
2
2
2
2
2
2
2
2
2
2
2
1
3
1
2
2
1
0
PP&E Gross
22
27
25
31
1
1
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
17
21
16
18
5
5
5
4
5
4
5
4
0
0
0
0
0
0
0
0
0
0
0
0
Intangible Assets
5
6
5
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
1
1
0
0
0
0
0
Long-Term Investments
0
0
1
1
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
127
N/A
184
+45%
184
0%
188
+3%
33
-82%
17
-48%
18
+2%
21
+18%
21
+0%
23
+9%
21
-8%
20
-3%
18
-13%
16
-7%
15
-9%
16
+8%
16
-3%
9
-45%
6
-30%
4
-33%
4
-14%
4
+20%
3
-40%
2
-32%
Liabilities
Accounts Payable
77
131
109
115
2
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
Accrued Liabilities
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
2
4
5
6
4
3
1
1
1
0
1
2
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
1
1
1
3
0
0
2
2
3
4
3
3
4
3
2
6
7
1
Other Current Liabilities
1
0
16
16
3
2
1
3
2
2
2
1
0
0
0
0
0
0
0
2
2
2
2
1
Total Current Liabilities
80
135
130
137
8
6
5
7
5
6
4
4
3
3
4
5
4
4
5
5
5
9
10
4
Long-Term Debt
0
0
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
2
1
1
1
0
2
Deferred Income Tax
2
2
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
13
13
12
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
5
6
15
16
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
Total Liabilities
99
N/A
157
+58%
159
+1%
165
+4%
9
-95%
7
-21%
6
-21%
8
+47%
6
-28%
7
+19%
4
-36%
5
+7%
3
-29%
3
-1%
4
+33%
5
+21%
5
-12%
5
-3%
7
+60%
6
-16%
7
+12%
10
+45%
11
+11%
7
-37%
Equity
Common Stock
30
30
30
30
30
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
17
Retained Earnings
2
0
5
6
2
1
1
3
4
5
6
5
0
1
4
3
3
10
15
16
18
20
23
25
Additional Paid In Capital
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
8
6
3
3
4
4
4
5
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
2
Total Equity
27
N/A
27
-1%
25
-8%
24
-6%
24
+3%
10
-58%
12
+18%
13
+5%
15
+20%
16
+5%
17
+5%
16
-5%
14
-8%
13
-9%
11
-19%
11
+2%
11
+2%
4
-63%
1
N/A
2
-70%
3
-65%
6
-72%
8
-47%
5
+38%
Total Liabilities & Equity
127
N/A
184
+45%
184
0%
188
+3%
33
-82%
17
-48%
18
+2%
21
+18%
21
+0%
23
+9%
21
-8%
20
-3%
18
-13%
16
-7%
15
-9%
16
+8%
16
-3%
9
-45%
6
-30%
4
-33%
4
-14%
4
+20%
3
-40%
2
-32%
Shares Outstanding
Common Shares Outstanding
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
90

See Also

Summary
BAC intrinsic value, competitors valuation, and company profile.
DCF Valuation
BAC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BAC stock valuation using valuation multiples.
Wall Street Estimates
BAC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BAC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 317,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.